Risk factors and impact of recurrent lupus nephritis in patients with systemic lupus erythematosus undergoing renal transplantation: Data from a single US institution

Arthritis and Rheumatism

Volumn 60, Issue 9, 2009, Pages 2757-2766

  Burgos, Paula I ^a   Perkins, Elizabeth L ^a   Pons Estel, Guillermo J ^a   Kendrick, Scott A ^a   Liu, Jigna M ^a   Kendrick, William T ^a   Cook, William J ^a   Julian, Bruce A ^a   Alarcón, Graciela S ^a   Kew II, Clifton E ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GLUCOCORTICOID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADOLESCENT; ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ARTICLE; CHRONIC GRAFT REJECTION; DEATH; DISEASE DURATION; ETHNICITY; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; KIDNEY ALLOGRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RECURRENT DISEASE; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SURVIVAL ANALYSIS; UNITED STATES; YOUNG ADULT;

EID: 69449106893     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.24776     Document Type: Article

References (48)

1. Bastian HM, Roseman JM, McGwin G Jr, Alarcon GS, Friedman AW, Fessler BJ, et al. Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis. Lupus 2002;11:152-160
2. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al, European Working Party on Systemic Lupus Erythematosus. Morbidity and mortality in systemic lupus erythematosus during a 5-year period: a multicenter prospective study of 1,000 patients. Medicine (Baltimore) 1999;78:167-175
3. Cameron JS. Lupus nephritis. J Am Soc Nephrol 1999;10:413-424
4. Wallace DJ, Podell TE, Weiner JM, Cox MB, Klinenberg JR, Forouzesh S. Lupus nephritis: experience with 230 patients in a private practice from 1950 to 1980. Am J Med 1982;72:209-220
5. Mojcik CF, Klippel JH. End-stage renal disease and systemic lupus erythematosus. Am J Med 1996;101:100-107 (Pubitemid 26285947)
6. Cheigh JS, Stenzel KH. End-stage renal disease in systemic lupus erythematosus. Am J Kidney Dis 1993;21:2-8. (Pubitemid 23062764)
7. Renal transplantation in congenital and metabolic diseases: a report from the ASC/NIH renal transplant registry. JAMA 1975;232:148-153
8. Bunnapradist S, Chung P, Peng A, Hong A, Chung P, Lee B, et al. Outcomes of renal transplantation for recipients with lupus nephritis: analysis of the Organ Procurement and Transplantation Network database. Transplantation 2006;82:612-618 (Pubitemid 44395229)
9. Ponticelli C, Moroni G. Renal transplantation in lupus nephritis. Lupus 2005;14:95-98
10. Stone JH, Amend WJ, Criswell LA. Outcome of renal transplantation in ninety-seven cyclosporine-era patients with systemic lupus erythematosus and matched controls. Arthritis Rheum 1998;41:1438-1445 (Pubitemid 28373124)
11. Moroni G, Tantardini F, Gallelli B, Quaglini S, Banfi G, Poli F, et al. The long-term prognosis of renal transplantation in patients with lupus nephritis. Am J Kidney Dis 2005;45:903-911 (Pubitemid 43181050)
12. Stone JH, Amend WJ, Criswell LA. Antiphospholipid antibody syndrome in renal transplantation: occurrence of clinical events in 96 consecutive patients with systemic lupus erythematosus. Am J Kidney Dis 1999;34:1040-1047
13. Bartosh SM, Fine RN, Sullivan EK. Outcome after transplantation of young patients with systemic lupus erythematosus: a report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation 2001;72:973-978 (Pubitemid 32879884)
14. Nyberg G, Karlberg I, Svalander C, Hedman L, Blohme I. Renal transplantation in patients with systemic lupus erythematosus: increased risk of early graft loss. Scand J Urol Nephrol 1990;24:307-313 (Pubitemid 20379741)
15. Stone JH, Amend WJ, Criswell LA. Outcome of renal transplantation in systemic lupus erythematosus. Semin Arthritis Rheum 1997;27:17-26. (Pubitemid 27374245)
16. Bumgardner GL, Mauer SM, Payne W, Dunn DL, Sutherland DE, Fryd DS, et al. Single-center 1-15-year results of renal transplantation in patients with systemic lupus erythematosus. Transplantation 1988;46:703-709 (Pubitemid 19017045)
17. Stone JH. End-stage renal disease in lupus: disease activity, dialysis, and the outcome of transplantation. Lupus 1998;7:654-659 (Pubitemid 29008235)
18. Azevedo LS, Romao JE Jr, Malheiros D, Saldanha LB, Ianhez LE, Sabbaga E. Renal transplantation in systemic lupus erythematosus: a case control study of 45 patients. Nephrol Dial Transplant 1998;13:2894-2898 (Pubitemid 28479541)
19. Goral S, Ynares C, Shappell SB, Snyder S, Feurer ID, Kazancioglu R, et al. Recurrent lupus nephritis in renal transplant recipients revisited: it is not rare. Transplantation 2003;75:651-656 (Pubitemid 36337363)
20. Yu TM, Chen YH, Lan JL, Cheng CH, Chen CH, Wu MJ, et al. Renal outcome and evolution of disease activity in Chinese lupus patients after renal transplantation. Lupus 2008;17:687-694
21. Lionaki S, Kapitsinou PP, Iniotaki A, Kostakis A, Moutsopoulos HM, Boletis JN. Kidney transplantation in lupus patients: a case-control study from a single centre. Lupus 2008;17:670-675
22. Cohen AS, Reynolds WE, Franklin EC, Kulka JP, Ropes MW, Shulman L, et al. Preliminary criteria for the classification of systemic lupus erythematosus. Bull Rheum Dis 1971;21:643-648
23. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-1277 (Pubitemid 13221242)
24. Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.
25. Kendrick SA, Kendrick WT, Cook WJ, Julian BA, Kew CE II. Recurrent lupus nephritis after renal transplantation: a single center experience [abstract]. Am J Transplantation 2008;8(Suppl 2):299.
26. Churg J, Bernstein J, Glassock RJ. Renal disease: classification and atlas of glomerular disease. 2nd ed. Tokyo: Igaku-Shoin; 1995. p. 151-179
27. Grimbert P, Frappier J, Bedrossian J, Legendre C, Antoine C, Hiesse C, et al, Groupe Cooperatif de Transplantation d'île de France. Long-term outcome of kidney transplantation in patients with systemic lupus erythematosus: a multicenter study. Transplantation 1998;66:1000-1003
28. Ansari A, Larson PH, Bates HD. Vascular manifestations of systemic lupus erythematosus. Angiology 1986;37:423-432 (Pubitemid 16033115)
29. Tang H, Chelamcharla M, Baird BC, Shihab FS, Koford JK, Goldfarb-Rumyantzev AS. Factors affecting kidney-transplant outcome in recipients with lupus nephritis. Clin Transplant 2008;22:263-272 (Pubitemid 351689656)
30. Dooley MA, Hogan S, Jennette C, Falk R, Glomerular Disease Collaborative Network. Cyclophosphamide therapy for lupus nephritis: poor renal survival in black Americans. Kidney Int 1997;51:1188-1195
31. Fernandez M, Alarcon GS, Calvo-Alen J, Andrade R, McGwin G Jr, Vila LM, et al, for the LUMINA Study Group. A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE. Arthritis Rheum 2007;57:576-584
32. Duran S, Apte M, Alarcon GS, for the LUMINA study group. Poverty, not ethnicity, accounts for the differential mortality rates among lupus patients of various ethnic groups. J Natl Med Assoc 2007;99:1196-1198 (Pubitemid 47614593)
33. Sacks JJ, Helmick CG, Langmaid G, Sniezek JE, for the Centers for Disease Control and Prevention. Trends in deaths from systemic lupus erythematosus - United States, 1979-1998. MMWR Morb Mortal Wkly Rep 2002;51:371-374
34. Walsh SJ, Algert C, Gregorio DI, Reisine ST, Rothfield NF. Divergent racial trends in mortality from systemic lupus erythematosus. J Rheumatol 1995;22:1663-1668
35. Alarcon GS, McGwin G Jr, Petri M, Reveille JD, Ramsey-Goldman R, Kimberly RP, for the PROFILE Study Group. Baseline characteristics of a multiethnic lupus cohort: PROFILE [published erratum appears in Lupus 2002;11:402]. Lupus 2002;11:95-101.
36. Alarcon GS, Friedman AW, Straaton KV, Moulds JM, Lisse J, Bastian HM, et al. Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs. Nurture. Lupus 1999;8:197-209.
37. Walsh SJ, Algert C, Rothfield NF. Racial aspects of comorbidity in systemic lupus erythematosus. Arthritis Care Res 1996;9:509-516 (Pubitemid 27036048)
38. Alarcon GS, Bastian HM, Beasley TM, Roseman JM, Tan FK, Fessler BJ, et al. Systemic lupus erythematosus in a multi-ethnic cohort (LUMINA): contributions of admixture and socioeconomic status to renal involvement. Lupus 2006;15:26-31.
39. Alarcon GS, McGwin G Jr, Petri M, Ramsey-Goldman R, Fessler BJ, Vila LM, et al, for the PROFILE Study Group. Time to renal disease and end-stage renal disease in PROFILE: a multiethnic lupus cohort. PLoS Med 2006;3:e396.
40. Bastian HM, Alarcon GS, Roseman JM, McGwin G Jr, Vila LM, Fessler BJ, for the LUMINA study group. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XLII. Factors predictive of new and worsening proteinuria. Rheumatology (Oxford) 2007;46:683-689
41. Alarcon GS, McGwin G Jr, Bartolucci AA, Roseman J, Lisse J, Fessler BJ, et al, for the LUMINA Study Group. Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual. Arthritis Rheum 2001;44:2797-2806
42. Vila LM, Alarcon GS, McGwin G Jr, Friedman AW, Baethge BA, Bastian HM, et al, for the LUMINA Study Group. Early clinical manifestations, disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulations. Rheumatology (Oxford) 2004;43:358-363
43. Pons Estel GJ, Alarcon GS, McGwin G Jr, Danila MI, Zhang J, Bastian HM, et al. Protective effect of hydroxychloroquine on renal damage in patients with systemic lupus erythematosus: data from a multiethnic cohort. Arthritis Rheum 2009;61:830-839
44. Ramirez RR, de la Cruz GP. The Hispanic population in the United States: March 2002. In: Current population reports. US Census Bureau, June 2003. http://www.census.gov/prod/2003pubs/p20-545.
45. Lochhead KM, Pirsch JD, D'Alessandro AM, Knechtle SJ, Kalayoglu M, Sollinger HW, et al. Risk factors for renal allograft loss in patients with systemic lupus erythematosus. Kidney Int 1996;49:512-517 (Pubitemid 26050328)
46. Chelamcharla M, Javaid B, Baird BC, Goldfarb-Rumyantzev AS. The outcome of renal transplantation among systemic lupus erythematosus patients. Nephrol Dial Transplant 2007;22:3623-3630 (Pubitemid 350212497)
47. Ward MM, Studenski S. Clinical prognostic factors in lupus nephritis: the importance of hypertension and smoking. Arch Intern Med 1992;152:2082-2088
48. Benowitz NL. Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment. Prog Cardiovasc Dis 2003;46:91-111. (Pubitemid 37013221)